Xiaoyan Michelle Zhang - Net Worth and Insider Trading

Xiaoyan Michelle Zhang Net Worth

The estimated net worth of Xiaoyan Michelle Zhang is at least $58,369 dollars as of 2024-04-29. Xiaoyan Michelle Zhang is the Chief Scientific Officer of Ikena Oncology Inc and owns about 44,475 shares of Ikena Oncology Inc (IKNA) stock worth over $58,369. Details can be seen in Xiaoyan Michelle Zhang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Xiaoyan Michelle Zhang has not made any transactions after 2022-01-11 and currently still holds the listed stock(s).

Transaction Summary of Xiaoyan Michelle Zhang

To

Xiaoyan Michelle Zhang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Xiaoyan Michelle Zhang owns 1 companies in total, including Ikena Oncology Inc (IKNA) .

Click here to see the complete history of Xiaoyan Michelle Zhang’s form 4 insider trades.

Insider Ownership Summary of Xiaoyan Michelle Zhang

Ticker Comapny Transaction Date Type of Owner
IKNA Ikena Oncology Inc 2022-01-11 Chief Scientific Officer

Xiaoyan Michelle Zhang Latest Holdings Summary

Xiaoyan Michelle Zhang currently owns a total of 1 stock. Xiaoyan Michelle Zhang owns 44,475 shares of Ikena Oncology Inc (IKNA) as of January 11, 2022, with a value of $58,369.

Latest Holdings of Xiaoyan Michelle Zhang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IKNA Ikena Oncology Inc 2022-01-11 44,475 1.31 58,369

Holding Weightings of Xiaoyan Michelle Zhang


Xiaoyan Michelle Zhang Form 4 Trading Tracker

According to the SEC Form 4 filings, Xiaoyan Michelle Zhang has made a total of 2 transactions in Ikena Oncology Inc (IKNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ikena Oncology Inc is the sale of 1,000 shares on January 11, 2022, which brought Xiaoyan Michelle Zhang around $12,000.

Insider Trading History of Xiaoyan Michelle Zhang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Xiaoyan Michelle Zhang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Xiaoyan Michelle Zhang Ownership Network

Ownership Network List of Xiaoyan Michelle Zhang

No Data

Ownership Network Relation of Xiaoyan Michelle Zhang


Xiaoyan Michelle Zhang Owned Company Details

What does Ikena Oncology Inc do?

Who are the key executives at Ikena Oncology Inc?

Xiaoyan Michelle Zhang is the Chief Scientific Officer of Ikena Oncology Inc. Other key executives at Ikena Oncology Inc include CFO & Head of Corp. Dev. Jotin Marango , Principal Accounting Officer Francisco Oliveira , and 10 percent owner Atlas Venture Fund Xi, L.p. .

Ikena Oncology Inc (IKNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ikena Oncology Inc (IKNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ikena Oncology Inc (IKNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ikena Oncology Inc (IKNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ikena Oncology Inc Insider Transactions

No Available Data

Xiaoyan Michelle Zhang Mailing Address

Above is the net worth, insider trading, and ownership report for Xiaoyan Michelle Zhang. You might contact Xiaoyan Michelle Zhang via mailing address: C/o Ikena Oncology, Inc., 645 Summer Street Suite 101, Boston Ma 02210.

Discussions on Xiaoyan Michelle Zhang

No discussions yet.